Literature DB >> 3611089

Three direct repeats and a TATA-like sequence are required for regulated expression of the human low density lipoprotein receptor gene.

T C Südhof, D R Van der Westhuyzen, J L Goldstein, M S Brown, D W Russell.   

Abstract

The low density lipoprotein receptor is encoded by a "housekeeping" gene that is transcribed in most mammalian cells and is subject to negative feedback regulation by sterols. To determine the basis for this regulated expression, we performed a transfection analysis with hybrid genes containing up to 6500 base pairs of 5' flanking DNA from the low density lipoprotein receptor gene fused to the coding region of the bacterial chloramphenicol acetyltransferase gene. These studies identified a 177-base pair fragment of 5' flanking DNA that is sufficient for expression as well as negative regulation by sterols. The positive elements within this region were further defined by analysis of a series of 15 mutations in which overlapping 10-base pair segments were scrambled by site-specific mutagenesis. These studies identified the positive elements as three imperfect direct repeats of 16 base pairs and a TATA-like sequence. The three repeats contain a sequence that is homologous to the consensus DNA sequence recognized by transcription factor Sp1.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3611089

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Identification of an essential cis-acting element (TR2-PACE) in the 5' promoter of human TR2 orphan receptor gene.

Authors:  D L Lin; C Chang
Journal:  Endocrine       Date:  2000-02       Impact factor: 3.633

2.  Promoter selective transcriptional synergy mediated by sterol regulatory element binding protein and Sp1: a critical role for the Btd domain of Sp1.

Authors:  J N Athanikar; H B Sanchez; T F Osborne
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

3.  Identification of essential nucleotides of the FP1 element responsible for enhancement of low density lipoprotein receptor gene transcription.

Authors:  P Dhawan; R Chang; K D Mehta
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

4.  Quantitative effects of common genetic variations in the 3'UTR of the human LDL-receptor gene and their associations with plasma lipid levels in the Atherosclerosis Risk in Communities study.

Authors:  Hind Muallem; Kari E North; Masao Kakoki; Mary K Wojczynski; Xia Li; Megan Grove; Eric Boerwinkle; Kirk C Wilhelmsen; Gerardo Heiss; Nobuyo Maeda
Journal:  Hum Genet       Date:  2007-02-02       Impact factor: 4.132

Review 5.  Human low-density lipoprotein receptor gene and its regulation.

Authors:  Wei-Jia Kong; Jingwen Liu; Jian-Dong Jiang
Journal:  J Mol Med (Berl)       Date:  2005-11-16       Impact factor: 4.599

Review 6.  Review of progress in sterol oxidations: 1987-1995.

Authors:  L L Smith
Journal:  Lipids       Date:  1996-05       Impact factor: 1.880

7.  Specificity in cholesterol regulation of gene expression by coevolution of sterol regulatory DNA element and its binding protein.

Authors:  J N Athanikar; T F Osborne
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

8.  Multiple crm- mutations in familial hypercholesterolemia. Evidence for 13 alleles, including four deletions.

Authors:  H H Hobbs; E Leitersdorf; J L Goldstein; M S Brown; D W Russell
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

9.  Domains of transcription factor Sp1 required for synergistic activation with sterol regulatory element binding protein 1 of low density lipoprotein receptor promoter.

Authors:  L Yieh; H B Sanchez; T F Osborne
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

10.  Characterization of tissue-specific transcription by the human synapsin I gene promoter.

Authors:  G Thiel; P Greengard; T C Südhof
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.